Kala Pharmaceuticals Inc. buy HC Wainwright
Start price
17.05.24
/
50%
€6.08
Target price
17.05.25
€16.55
Performance (%)
-11.52%
Price
29.08.24
€5.22
Summary
This prediction is currently active. The price of Kala Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.52%. This prediction currently runs until 17.05.25. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Kala Pharmaceuticals Inc. | 0.675% | 0.675% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by HC_Wainwright for this prediction
In the thread Kala Pharmaceuticals diskutieren
KALA BIO, Inc. (NASDAQ: KALA) had its price target lowered by analysts at HC Wainwright from $21.00 to $18.00. They now have a "buy" rating on the stock.
Ratings data for KALA provided by MarketBeat
Stopped prediction by HC_Wainwright for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.37
02.04.24
02.04.24
€19.50
02.04.25
02.04.25
-27.02%
29.08.24
29.08.24
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.00
17.11.23
17.11.23
€20.23
17.11.24
17.11.24
5.70%
29.08.24
29.08.24
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€12.63
11.08.23
11.08.23
€21.91
11.08.24
11.08.24
-57.52%
12.08.24
12.08.24
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.19
27.03.23
27.03.23
€18.53
27.03.24
27.03.24
-44.50%
28.03.24
28.03.24